Ex Parte GIORIA - Page 7



          Appeal No. 2001-0964                                                        
          Application No. 09/069,442                                                  

          The Section 103 Rejections                                                  
               Concerning the Section 103 rejection of appealed independent           
          claim 1, we agree with the examiner’s conclusion that it would              
          have been obvious for an artisan with ordinary skill to formulate           
          an electroplating bath and thereby obtain an electrodeposit which           
          contain ingredients such as the here claimed iron, zirconium and            
          gold and which are free of cobalt, cadmium and nickel ions.  This           
          is because Korbelak expressly teaches formulating an                        
          electroplating bath (and consequently an electrodeposit) from a             
          listing of ingredients which includes iron, zirconium and gold              
          (as well as a citrate, and a weak acid; compare appealed                    
          independent claim 4) as fully explained in the answer.  Although            
          Korbelak discloses a large number of possible ingredient                    
          formulations for his electroplating bath and does not highlight             
          the particular formulation here claimed, an obviousness                     
          conclusion is appropriate because each of the formulations                  
          embraced by patentee’s broad disclosure are generically taught as           
          being effective and because Section 103 does not require that the           
          here claimed formulation be taught by the prior art as preferred.           
          Merck & Co. v. Biocraft Labs., Inc., 874 F.2d 804, 807-08,                  
          10 USPQ2d 1843, 1846 (Fed. Cir.), cert. denied, 493 U.S.                    
          975 (1989).                                                                 
                                          7                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007